Additionally, new tests from Genetic Technologies LTD and Phenogen Sciences Inc . comparing non-coding DNA to a woman's lifetime exposure to estrogen can now determine a woman's probability of developing estrogen positive breast cancer also known as sporadic breast cancer ( the most prevalent form of breast cancer ).
मोबाइल